These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 996855)

  • 1. [Salbutamol therapy of chronic bronchopathic patients with cardiac arrhythmias].
    Del Torre L; Fiore G; Macluso S; Pesce L
    Torace; 1976 Jan; 18(1-2):40-51. PubMed ID: 996855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart-rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease.
    Rossinen J; Partanen J; Stenius-Aarniala B; Nieminen MS
    J Intern Med; 1998 May; 243(5):361-6. PubMed ID: 9651558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salbutamol and cardiac arrhythmias.
    Crawford SM; Miles DW
    Curr Med Res Opin; 1981; 7(6):410-5. PubMed ID: 7238086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the ventilatory and cardiocirculatory effects of a beta-2-stimulating drug (salbutamol) in patients with the respiratory dysfunctional syndrome of the obstructive type].
    Melillo G; D'Amato G; Cocco G
    Minerva Med; 1976 Mar; 67(15):964-8. PubMed ID: 1264368
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of the bronchodilator action of salbutamol and orciprenaline by aerosol administration in patients with chronic bronchopneumopathy].
    Sorbini CA; Todisco T; Boschetti E
    Minerva Med; 1976 Mar; 67(16):1079-83. PubMed ID: 1264384
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease.
    Crane J; Burgess CD; Graham AN; Maling TJ
    N Z Med J; 1987 May; 100(824):309-11. PubMed ID: 3330186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience with delayed-action salbutamol].
    Zanotelli F
    Minerva Med; 1976 Mar; 67(16):1019-22. PubMed ID: 1264374
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the effects of salbutamol in chronic obstructive bronchopneumopathies].
    Camerota G; Pontiggia P; Curti PC
    Minerva Med; 1976 Mar; 67(16):1025-6. PubMed ID: 1264376
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind comparison of a microcrystalline theophylline tablet and salbutamol in reversible airways obstruction.
    Tedders JG; Thomas AK; Edwards G
    Br J Clin Pract; 1976; 30(11-12):212-6. PubMed ID: 795447
    [No Abstract]   [Full Text] [Related]  

  • 10. [Respiratory, cardiological and metabolic functional studies of the effects of salbutamol in bronchopathic patients of various ages].
    Babolini G; Gemelli M; Capone M; Coglitore G; Ministeri S; Girbino G; Pinizzotto G; Barberio G
    Minerva Med; 1976 Mar; 67(16):1058-66. PubMed ID: 1264381
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of the bronchodilator action of fenoterol and salbutamol by aerosol administration in patients with bronchial asthma].
    Todisco T; Ansidei V; Miele N; Porcellati C; Sorbini CA
    Minerva Med; 1975 Dec; 66(84):4535-45. PubMed ID: 1202407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Response of airflow to the administration of bronchodilator agents in patients with chronic obstructive lung disease or asthma].
    Barbas CS; Barbas Filho JV; do Amaral e Silva E; Stávale ML; Amato Mde P
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):163-5. PubMed ID: 1843712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the bronchodilator effects of broxaterol and salbutamol.
    Casali L; Rossi A; Manazza P; Colombo ML; Zoia MC
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):93-7. PubMed ID: 2900816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the heart rhythm and slow-release beta-2 agonist therapy (peroral) in asthmatic patients. A Holter study].
    Malerba M; Politi A; Filippi B; Zambruni U; Grassi V
    Recenti Prog Med; 1992 Dec; 83(12):665-71. PubMed ID: 1494703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the bronchodilating effect of TH 1165 A and of salbutamol in patients with spastic obstructive ventilatory syndrome].
    Iaia E; Cagnazzo R; Digilio VS; Scoditti A
    Clin Ter; 1981 Dec; 99(5):499-505. PubMed ID: 7333071
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results in the testing of salbutamol (Ventolin) and orciprenaline using plethysmography in patients with obstructive pulmonary diseases].
    Paulin A
    Plucne Bolesti Tuberk; 1972; 24(4):320-3. PubMed ID: 4671423
    [No Abstract]   [Full Text] [Related]  

  • 17. [Over-8-hour salbutamol effect in obstructive respiratory tract diseases].
    Kersten W
    Fortschr Med; 1974 Apr; 92(11):487-91. PubMed ID: 4822455
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing asthma and COPD in patients with cardiovascular disease.
    George RB; Payne DK
    Geriatrics; 1985 Jul; 40(7):45-9. PubMed ID: 4007497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the effectiveness and tolerance of a new beta-2 stimulant (broxaterol) vs. salbutamol in patients with chronic obstructive bronchopneumopathy].
    Giosuè S; Guerrini P; Cafaggi R; D'Onofrio V; Perrone N; Scano M
    Clin Ter; 1987 Apr; 121(1):35-9. PubMed ID: 2885123
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bronchodilator action and side effects of salbutamol in patients with bronchospasm of the respiratory tract].
    Cesco G
    Minerva Med; 1976 Apr; 67(17):1151-4. PubMed ID: 1264393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.